Home Newsfeeds Argus Research Initiates Coverage On Haleon with Hold Rating

Argus Research Initiates Coverage On Haleon with Hold Rating

Argus Research analyst Taylor Conrad initiates coverage on Haleon (NYSE:HLN) with a Hold rating.

byBenzinga Newsdesk

September 28, 2022

1 minute read

Argus Research analyst Taylor Conrad initiates coverage on Haleon (NYSE:HLN) with a Hold rating.

Ahead Of Tesla’s Q4 Earnings, Analyst Positive Despite Muted Outlook For Margin, New Product Ramp-up

By Shanthi Rexaline

January 21, 2:46 PM

A Tesla bull concedes that near-term is a cause of worry, although he remains positive regarding the long-term fundamentals.

TSLA

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic

By Lara Goldstein

September 18, 4:30 PM

Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.)

MSSTF

News

5 Value Stocks In The Consumer Defensive Sector

By Benzinga Insights

January 13, 10:39 AM

Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are…

AGRO

Special Opportunities Fund, Raises Dividend From $0.11 To $0.171875 per share

By Benzinga Newsdesk

September 7, 10:16 AM

Special Opportunities Fund, Inc. (NYSE:SPE) (the "Fund") today announced that the Fund's Board of Directors has declared a cash dividend of $0.171875 per share on the Fund's 2.75% Convertible Preferred Stock, Series C.

SPE

Argus Research Initiates Coverage On Haleon with Hold Rating

Related Posts

Ahead Of Tesla’s Q4 Earnings, Analyst Positive Despite Muted Outlook For Margin, New Product Ramp-up

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic

5 Value Stocks In The Consumer Defensive Sector

Special Opportunities Fund, Raises Dividend From $0.11 To $0.171875 per share